Lung, pleural and colon actinomycosis in an immunocompromised patient: a rare form of presentation
dc.contributor.author | Charalabopoulos, K. | en |
dc.contributor.author | Charalabopoulos, A. K. | en |
dc.contributor.author | Papalimneou, V. | en |
dc.contributor.author | Ioachim, E. | en |
dc.contributor.author | Constantopoulos, S. H. | en |
dc.date.accessioned | 2015-11-24T19:05:59Z | |
dc.date.available | 2015-11-24T19:05:59Z | |
dc.identifier.issn | 0009-3157 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20279 | |
dc.rights | Default Licence | - |
dc.subject | Actinomycosis/*diagnosis/immunology | en |
dc.subject | Aged | en |
dc.subject | Biopsy, Needle | en |
dc.subject | Colonic Diseases/*diagnosis/immunology | en |
dc.subject | Diagnosis, Differential | en |
dc.subject | Humans | en |
dc.subject | *Immunocompromised Host | en |
dc.subject | Lung Diseases/*diagnosis/immunology | en |
dc.subject | Lung Diseases, Fungal/*diagnosis/immunology | en |
dc.subject | Male | en |
dc.subject | Pleural Diseases/*diagnosis/immunology | en |
dc.subject | Tomography Scanners, X-Ray Computed | en |
dc.title | Lung, pleural and colon actinomycosis in an immunocompromised patient: a rare form of presentation | en |
heal.abstract | Actinomycosis is caused by gram-positive filamentous organisms of the genus Actinomyces, which may spread through trauma. Most commonly, it is a cervicofacial disease due to dental infection or a thoracic disease secondary to aspiration of foreign bodies. Primary abdominal infection usually follows some form of mucosal disruption. Any organ of the human body may be involved so that a wide range of symptoms may be present. We report a rare form of actinomycosis involving the lung, pleura and colon concomitantly in an immunocompromised patient. A fine needle aspiration from a lung lesion detected the characteristic sulfur granules, and a pleural effusion culture confirmed the diagnosis. Clinical manifestations and treatment are discussed. Actinomycetes are rarely opportunistic agents in immunocompromised patients; thus the disease deserves special attention in those patients. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1159/000071147 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/12886058 | - |
heal.identifier.secondary | http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000071147 | - |
heal.journalName | Chemotherapy | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2003 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: